Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia

Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.
No abstract available

Keywords: Bruton’s tyrosine kinase (BTK) inhibitors; Chronic lymphocytic leukemia; Cryptococcosis; Fungal infections; Ibrutinib.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / analogs & derivatives
  • Aged, 80 and over
  • Cryptococcosis* / chemically induced
  • Cryptococcosis* / metabolism
  • Cryptococcosis* / pathology
  • Dermatomycoses* / chemically induced
  • Dermatomycoses* / metabolism
  • Dermatomycoses* / pathology
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell* / microbiology
  • Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
  • Piperidines
  • Pyrazoles / administration & dosage
  • Pyrazoles / adverse effects*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine